13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q1 2025. See the latest, Q2 2026 →
Reported value
$617.20B
−6.3% on the quarter before
Positions
552
44 new · 35 sold out
Top 10
28.0%
of the value
Est. gain
−$20.91B
on stocks held all quarter
Est. return
−3.5%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$3.18BAdded · 0.3% → 0.8%+10,205,899 shares
- Starbucks Corp~$1.92BAdded · 0.8% → 1.2%+19,542,190 shares
- Apple~$1.74BAdded · 1.2% → 1.4%+7,833,045 shares
- Intel~$1.25BAdded · 0.0% → 0.2%+54,973,681 shares
- Gallagher Arthur J & Co~$1.17BAdded · 0.4% → 0.6%+3,374,770 shares
- Micron~$1.15BAdded · 0.5% → 0.8%+13,185,983 shares
- Citigroup Inc~$1.11BAdded · 0.3% → 0.5%+15,576,685 shares
- Nike Inc~$1.05BAdded · 0.3% → 0.4%+16,495,958 shares
- Philip Morris Intl Inc~$1.03BAdded · 2.2% → 3.3%+6,518,882 shares
- Abbott Labs~$1.02BAdded · 0.0% → 0.2%+7,667,348 shares
Largest sells
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$7.01BCut · 6.9% → 4.2%−41,868,805 shares
- Caterpillar Inc~$2.75BCut · 0.9% → 0.4%−8,324,751 shares
- Home Depot Inc~$2.08BCut · 1.2% → 0.8%−5,663,141 shares
- Gilead Sciences Inc~$2.03BCut · 1.0% → 1.0%−18,158,461 shares
- Extra Space Storage Inc~$1.98BCut · 0.5% → 0.2%−13,346,207 shares
- Canadian Nat Res Ltd~$1.77BCut · 1.2% → 1.0%−57,442,431 shares
- Target Corp~$1.72BCut · 0.5% → 0.1%−16,474,020 shares
- Southwest Airls Co~$1.65BCut · 0.3% → 0.0%−49,073,820 shares
- Dell Technologies Inc~$1.44BSold out · 0.2% → 0.0%−12,460,949 shares
- Eaton Corp Plc~$1.36BSold out · 0.2% → 0.0%−4,085,154 shares
Holdings
As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares −21% · price −27.8% | 4.2% | $25.97B | −$9.99B | ||||||||
| MicrosoftCOM · shares −2.8% · price −10.9% | 4.0% | $24.93B | −$3.06B | ||||||||
| MetaCL A · shares −5.5% · price −1.6% | 3.6% | $21.95B | −$348.7M | ||||||||
| Philip Morris Intl IncCOM · shares +5.3% · price +31.9% | 3.3% | $20.49B | +$4.70B | ||||||||
| Eli LillyCOM · shares −6.0% · price +7.0% | 2.5% | $15.18B | +$990.7M | ||||||||
| NvidiaCOM · shares −0.9% · price −19.3% | 2.5% | $15.14B | −$3.62B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares +0.7% · price +20.4% | 2.2% | $13.83B | +$2.33B | ||||||||
| AmazonCOM · shares +1.0% · price −13.3% | 2.0% | $12.62B | −$1.91B | ||||||||
| Unitedhealth Group IncCOM · shares +5.9% · price +3.5% | 1.9% | $11.93B | +$384.1M | ||||||||
| NetflixCOM · shares −2.2% · price +4.6% | 1.7% | $10.74B | +$474.5M | ||||||||
| TeslaCOM · shares −2.3% · price −35.8% | 1.7% | $10.44B | −$5.83B | ||||||||
| AppleCOM · shares +24% · price −11.3% | 1.4% | $8.89B | −$910.9M | ||||||||
| Visa Inc.COM CL A · shares +0.5% · price +10.9% | 1.3% | $8.20B | +$800.7M | ||||||||
| Starbucks CorpCOM · shares +36% · price +7.5% | 1.2% | $7.30B | +$375.7M | ||||||||
| Canadian Nat Res LtdCOM · shares −22% · price −0.3% | 1.0% | $6.43B | −$20.5M | ||||||||
| Jpmorgan Chase & Co.COM · shares −13% · price +2.3% | 1.0% | $6.18B | +$140.4M | ||||||||
| AlphabetCAP STK CL A · shares +3.2% · price −18.3% | 0.98% | $6.08B | −$1.32B | ||||||||
| Gilead Sciences IncCOM · shares −25% · price +21.3% | 0.97% | $6.00B | +$1.05B | ||||||||
| Eog Res IncCOM · shares +1.3% · price +4.6% | 0.97% | $5.97B | +$259.9M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +17% · price −4.3% | 0.89% | $5.50B | −$213.4M | ||||||||
| Comcast Corp NewCL A · shares +4.4% · price −1.7% | 0.88% | $5.46B | −$89.4M | ||||||||
| Transdigm Group IncCOM · shares +3.6% · price +9.2% | 0.88% | $5.44B | +$439.9M | ||||||||
| AlphabetCAP STK CL C · shares +6.1% · price −18.0% | 0.86% | $5.31B | −$1.10B | ||||||||
| Amgen IncCOM · shares +157% · price +19.5% | 0.84% | $5.20B | +$330.6M | ||||||||
| Home Depot IncCOM · shares −29% · price −5.8% | 0.83% | $5.13B | −$315.5M | ||||||||
| Total · 552 positions | 100% | $617.20B | −$20.91B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 503 stocks held throughout, down $20.91B (−3.5%).
- Philip Morris Intl Inc+$4.70B+32%
- Vertex Pharmaceuticals Inc+$2.33B+20%
- Cvs Health Corp+$1.40B+51%
- Gilead Sciences Inc+$1.05B+21%
- Eli Lilly+$990.7M+7%
- Amazon−$1.91B−13%
- Microsoft−$3.06B−11%
- Nvidia−$3.62B−19%
- Tesla−$5.83B−36%
- Broadcom−$9.99B−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |